Synopsis of recent research by authors named "Nzeera Ketter"
- Nzeera Ketter's research focuses on understanding the transmission dynamics and health implications of the Omicron variant of SARS-CoV-2, particularly in populations with compromised immune systems, such as those living with HIV, revealing a notably high asymptomatic carriage rate in South Africa.
- Ketter has also contributed to Alzheimer’s disease research, particularly investigating amyloid-related imaging abnormalities associated with treatment using bapineuzumab in phases III clinical trials, aiming to evaluate both safety and efficacy of potential treatments.
- Another significant aspect of Ketter's research includes leading observational studies to identify biomarkers linked to Alzheimer’s disease, exploring cognitive health in aging populations, and assessing the long-term effects of interventions in milder stages of the disease.
